Anthracycline-based hepatic arterial infusion chemotherapy achieved 17 months of disease regression in a patient with breast cancer liver metastases resistant to multiple systemic chemotherapies-Reference-Cited by-同舟云学术

Anthracycline-based hepatic arterial infusion chemotherapy achieved 17 months of disease regression in a patient with breast cancer liver metastases resistant to multiple systemic chemotherapies

Published:2024-02-12 Issue:2 Volume:13 Page:153-157
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Kawashima Masahiro^ORCID,Matsumoto Takeshi,Nishimura Takao,Mashima Susumu,Kobayashi Atsushi,Kanemitsu Eisho,Nagata Hiromitsu,Tanaka Toshihiro,Shimahara Yasuyuki

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13691-024-00656-8.pdf

Reference19 articles.

1. Camacho LH, Kurzrock R, Cheung A et al (2007) Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer 109:2190–2196

2. Arai Y, Sone Y, Inaba AY, Kido C (1994) Hepatic arterial infusion chemotherapy for liver metastases from breast cancer. Cancer Chemother Pharmacol 33(Suppl):S142–S144

3. Aarts BM, Muñoz FMG, Wildiers H et al (2021) Intra-arterial therapies for liver metastatic breast cancer: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 44:1868–1882

4. Masuda T, Niizeki O, Niizeki T et al (2021) Successful treatment with hepatic arterial infusion chemotherapy in a breast cancer patient with multiple liver metastases who declined systemic therapy. Case Rep Oncol 14:1261–1265

5. Gofuku J, Yayoi E, Ikeda N et al (2004) Long-term survivors with liver metastasis from breast cancer who were received intra-arterial chemotherapy. Gan To Kagaku Ryoho 31:1828–1831

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-04-13